HONcode

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trust worthy health information:
verify here.


Search only trustworthy HONcode health websites:

Affiliations

REACTION is affilliated with these programs and organisations:

REACTION is delivering better and more efficient healthcare services in Europe, thus supporting the Commissions activities in ICT for Health: eHealth.



The REACTION platform allows for the creation of inclusive applications with accessibility for all. The project supports the Commissions campaign: eInclusion - be part of it!



Facts



The REACTION project is a 4-year project started in 2010. It is partly funded by the European Commission under the 7th Framework Programme in the area of Personal Health Systems under Grant Agreement no. 248590

 Impressum   Privacy

Events

<< May 2019 >>
Mo Tu We Th Fr Sa Su
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

No events.


Previous Newsletters


Read previous issues of our newsletter here:

April 2014
August 2013
June 2012
August 2011
April 2011
November 2010

Share this

Bookmark and Share

eHealth at Facebook

Join the discussion on EC eHealth at Facebook!

Web Links: Medical science

A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes
Automated control of blood glucose (BG) concentration is a long-sought goal for type 1 diabetes therapy. We have developed a closed-loop control system that uses frequent measurements of BG concentration along with subcutaneous delivery of both the fast-acting insulin analog lispro and glucagon (to imitate normal physiology) as directed by a computer algorithm.

Firas H. El-Khatib et.al., Department of Biomedical Engineering, Boston University, Boston
Date Added:
18-05-2010
Visits: 1462
The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine supp
The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial.OBJECTIVE: To demonstrate that Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support significantly improves HbA(1c) in poorly controlled type 1 diabetic patients.
Date Added:
28-04-2011
Visits: 1487
Telemedicine Toolkit
COCIR, the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry, has collected a large number of clinical studies providing evidence of medical outcome of telemedicine solutions. The list can be found in the COCIR document.
Date Added:
24-01-2012
Visits: 1207